Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response.

@article{SalazardePablo2022SystematicRA,
  title={Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response.},
  author={Gonzalo Salazar de Pablo and Carolina Pastor Jord{\'a} and Julio Vaquerizo-Serrano and Carmen Moreno and Anna Cabras and Celso Arango and Patricia Hern{\'a}ndez and Jeremy Veenstra-VanderWeele and Emily Simonoff and Paolo Fusar-Poli and Paramala J Santosh and Samuele Cortese and Mara Parellada},
  journal={Journal of the American Academy of Child and Adolescent Psychiatry},
  year={2022}
}
1 Citations

Editorial: Weighing Benefits and Risks While Treating Irritability and Emotional Dysregulation in Autism.

  • M. Singh
  • Medicine
    Journal of the American Academy of Child and Adolescent Psychiatry
  • 2022

References

SHOWING 1-10 OF 100 REFERENCES

Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis

Placebo response in ASD was substantial and predicted by design- and participant-related factors, which could inform the design of future trials in order to improve the detection of efficacy in core symptoms.

Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis.

Risperidone and aripiprazole were the two best drugs, with comparable efficacy and safety in pediatric ASD patients, and these two medications could be beneficial in improving irritability in these patients.

Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.

  • R. RodriguesM. Lai S. Ameis
  • Psychology, Medicine
    Journal of child psychology and psychiatry, and allied disciplines
  • 2020
Direct pooled evidence supports the efficacy and tolerability of methylphenidate or atomoxetine for treatment of ADHD symptoms in children and youth with ASD.

Efficacy of Interventions Based on Applied Behavior Analysis for Autism Spectrum Disorder: A Meta-Analysis

Objective To systematically evaluate evidence for the use of interventions based on appied behavior analysis (ABA) to manage various symptoms of children with autism spectrum disorder (ASD). Methods

A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.

In this study, there was no statistically significant difference between aripiprazole and placebo in time to relapse during maintenance therapy, however, the HR and NNT suggest some patients will benefit from maintenance treatment.

Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability.

Risperidone can be individually titrated to optimal dosage for excellent response in the majority of children and is better with greater symptom severity, while weight gain is not necessary for ris peridone benefit and may even detract from it.

Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis

Although ADHD medications are superior to placebo, and placebo treatment in clinical practice is not feasible, clinicians should attempt to incorporate factors associated with placebo effects into clinical care.

A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorder

5-week of riluzole treatment was well tolerated, but had no significant effect on the target symptoms, and there were no statistically significant findings for the overall treatment effect, the treatment effect by week within period of the study, or a cross-over effect across the periods of theStudy.

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

  • R. MarcusR. Owen M. Aman
  • Psychology, Medicine
    Journal of the American Academy of Child and Adolescent Psychiatry
  • 2009
Aripiprazole was efficacious and generally safe and well tolerated in the treatment of children and adolescents with irritability associated with autistic disorder.
...